FDA OKs Neuron Therapeutics' lumbar catheter:
This article was originally published in Clinica
Executive Summary
The US FDA has cleared for sale Neuron Therapeutics' lumbar catheter for draining cerebrospinal fluid (CSF) from the space surrounding the spinal cord. Compared with existing lumbar drainage products, the new catheter can transport CSF at significantly higher flow rates, is less likely to collapse or become obstructed and has improved handling characteristics, claims the Malvern, Pennsylvania firm. The catheter is part of Neuron's investigational drug delivery system for treating central nervous system disorders, such as subarachnoid haemorrhage, spinal cord injury, traumatic brain injury and stroke.